OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
January 03, 2024
A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach.
Novel molecular glues are transforming targeted protein degradation.
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
Designers adopt value-added features, different materials, and enhanced coding technologies.
UK scientists are once again able to participate in the Horizon European research programme thanks to a deal struck in 2023.
January 02, 2024
Analytical methods and tools play a pivotal role in cleaning validation.
With the acquisition, AstraZeneca will gain a potential RSV and hMPV combination vaccine.
The EHDS aims to increase access to health data, but how will it impact pharma?
Clarivate has released its 2024 Drugs to Watch report, highlighting 13 therapies with great potential.
GSI shortages result from how hospitals buy GSI drugs, and the underinvestment in manufacturing operations that follow.